DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Mahaffey KW, Neal B, Perkovic V. et al.
Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events: Results From the CANVAS Program (Canagliflozin Cardiovascular Assessment Study).
Circulation. 2018;
137: 323-334
We do not assume any responsibility for the contents of the web pages of other providers.